Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

SELL
$27.42 - $43.63 $8,500 - $13,525
-310 Closed
0 $0
Q1 2021

Jun 17, 2021

SELL
$86.23 - $125.19 $2.46 Million - $3.57 Million
-28,492 Reduced 98.92%
310 $29,000
Q1 2021

Jun 08, 2021

BUY
$86.23 - $125.19 $2.48 Million - $3.61 Million
28,802 New
28,802 $29,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $512M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Prentice Wealth Management LLC Portfolio

Follow Prentice Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prentice Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prentice Wealth Management LLC with notifications on news.